Smart Skin Technologies Inc.

Published purpose

As part of Multinational Corporate Collaboration Program, the project IPSACCI will focus on developing a new technology called the Seal Assurance Platform that incorporates new container twin sensor hardware and software. The PoC has been tested with a Global Pharmaceutical Partner but there are several novel aspects that need to be researched, developed and trialed before the product can be validated and commercialized. Successfully completing this project will position SmartSkin’s solution to be eligible for use in 95% of capper lines at multinational locations versus only 25% today. This is a multi-million dollar opportunity at our Global Pharma Partner and opens a new market opportunity valued at over $200M.